These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7815100)
41. [Inhibitory effect of tumor growth by methionine-enkephalin]. Mascarenhas G; Quirico-Santos T Arq Neuropsiquiatr; 1992 Mar; 50(1):84-90. PubMed ID: 1339154 [TBL] [Abstract][Full Text] [Related]
42. Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor. Zagon IS; Smith JP; McLaughlin PJ Int J Oncol; 1999 Mar; 14(3):577-84. PubMed ID: 10024694 [TBL] [Abstract][Full Text] [Related]
43. Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model. Donahue RN; McLaughlin PJ; Zagon IS Exp Biol Med (Maywood); 2011 Sep; 236(9):1036-50. PubMed ID: 21807817 [TBL] [Abstract][Full Text] [Related]
44. Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively. Takemori AE; Portoghese PS Eur J Pharmacol; 1993 Sep; 242(2):145-50. PubMed ID: 8253111 [TBL] [Abstract][Full Text] [Related]
45. Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1. Pijuan-Thompson V; Grammer JR; Stewart J; Silverstein RL; Pearce SF; Tuszynski GP; Murphy-Ullrich JE; Gladson CL Exp Cell Res; 1999 May; 249(1):86-101. PubMed ID: 10328956 [TBL] [Abstract][Full Text] [Related]
46. Endogenous opioids and neural cancer: an immunoelectron microscopic study. Zagon IS Brain Res Bull; 1989 Jun; 22(6):1023-9. PubMed ID: 2790495 [TBL] [Abstract][Full Text] [Related]
47. Presynaptic actions of opioid receptor agonists in ventromedial hypothalamic neurons in estrogen- and oil-treated female mice. Devidze N; Zhang Q; Zhou J; Lee AW; Pataky S; Kow LM; Pfaff DW Neuroscience; 2008 Apr; 152(4):942-9. PubMed ID: 18343595 [TBL] [Abstract][Full Text] [Related]
48. Effect of opioid peptide methionine-enkephalin in long-term cultures of human bone marrow. Janda SS; Boranić M; Skodlar J; Petrovecki M; Nemet D; Labar B Acta Med Croatica; 2000; 54(3):99-105. PubMed ID: 11268793 [TBL] [Abstract][Full Text] [Related]
50. Human neuroblastoma cells use either insulin-like growth factor-I or insulin-like growth factor-II in an autocrine pathway via the IGF-I receptor: variability of IGF, IGF binding protein (IGFBP) and IGF receptor gene expression and IGF and IGFBP secretion in human neuroblastoma cells in relation to cellular proliferation. Kiess W; Koepf G; Christiansen H; Blum WF Regul Pept; 1997 Sep; 72(1):19-29. PubMed ID: 9404729 [TBL] [Abstract][Full Text] [Related]
51. Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO. Kow LM; Commons KG; Ogawa S; Pfaff DW Brain Res; 2002 May; 935(1-2):87-102. PubMed ID: 12062477 [TBL] [Abstract][Full Text] [Related]
52. Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation. Chakrabarti S; Law PY; Loh HH J Neurochem; 1998 Jul; 71(1):231-9. PubMed ID: 9648870 [TBL] [Abstract][Full Text] [Related]
53. In vivo effects of chronic treatment with [MET5]-enkephalin on hematological values and natural killer cell activity in athymic mice. Zalys R; Zagon IS; Bonneau RH; Lang CM; McLaughlin PJ Life Sci; 2000 Jan; 66(9):829-34. PubMed ID: 10698357 [TBL] [Abstract][Full Text] [Related]
54. Differential effects of transforming growth factor-beta(s) and glial cell line-derived neurotrophic factor on gene expression of presenilin-1 in human post-mitotic neurons and astrocytes. Ren RF; Lah JJ; Diehlmann A; Kim ES; Hawver DB; Levey AI; Beyreuther K; Flanders KC Neuroscience; 1999; 93(3):1041-9. PubMed ID: 10473269 [TBL] [Abstract][Full Text] [Related]
55. Methionine-enkephalin related glycoconjugates. Synthesis and biological activity. Horvat S; Horvat J; Varga-Defterdarović L; Pavelić K; Chung NN; Schiller PW Int J Pept Protein Res; 1993 Apr; 41(4):399-404. PubMed ID: 8496021 [TBL] [Abstract][Full Text] [Related]
56. Demonstration and characterization of zeta (zeta), a growth-related opioid receptor, in a neuroblastoma cell line. Zagon IS; Goodman SR; McLaughlin PJ Brain Res; 1990 Mar; 511(2):181-6. PubMed ID: 2159355 [TBL] [Abstract][Full Text] [Related]
57. Opioid receptor agonists and Ca2+ modulation in human B cell lines. Heagy W; Shipp MA; Finberg RW J Immunol; 1992 Dec; 149(12):4074-81. PubMed ID: 1334111 [TBL] [Abstract][Full Text] [Related]
58. An assessment of the role of opioid receptors in the response to cannabimimetic drugs. Devane WA; Spain JW; Coscia CJ; Howlett AC J Neurochem; 1986 Jun; 46(6):1929-35. PubMed ID: 3009717 [TBL] [Abstract][Full Text] [Related]
59. Enkephalin receptors and receptor-mediated signal transduction in cultured human lymphocytes. Heagy W; Teng E; Lopez P; Finberg RW Cell Immunol; 1999 Jan; 191(1):34-48. PubMed ID: 9918685 [TBL] [Abstract][Full Text] [Related]
60. The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice. Donahue RN; McLaughlin PJ; Zagon IS Gynecol Oncol; 2011 Aug; 122(2):382-8. PubMed ID: 21531450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]